Thanks for posting this intel. That's a very interesting transaction here with ETBI.
Maybe... just maybe... such a deal was consummated because of the belief that something is known to exist that justifies buying ETBI later at .05 per share of which will be considered at a discount and not at a premium at such time. I think having an insulin pill to take that will eliminate taking the insulin shot for people with diabetes could be something huge for ETBI and any Big Pharma that wants in:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138230450 Gunpowder also announced today that Eastgate has paid back, in full, the loan that Eastgate entered into with Gunpowder and that Gunpowder previously announced in its April 25th, 2017 press release. As previously disclosed in the April 25th, 2017 press release, and as part of the loan agreement between Eastgate and Gunpowder, Eastgate has issued One Million ("1,000,000") common stock purchase warrants to Gunpowder. The warrants shall have a life of three years, and allow for the purchase of 1,000,000 Eastgate common shares at a price of Five Cents ("$0.05") CDN per share
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.